US Executive Compensation Proxy SEC Filings — July 16, 2026

16-07-2026

OSR Health, Inc. filed a DEF 14A proxy statement ahead of its annual meeting, seeking shareholder approval for executive compensation (say-on-pay), an increase in authorized common shares from 100M to 250M, and ratification of its 2025 Omnibus Incentive Plan. A substantial portion of the proposed share increase is intended to finance a shareholder loyalty program that would issue additional shares to long-term holders if stock-price targets are met. The company remains an emerging growth company with no equity grants to named officers in FY2024 or FY2025 and no outstanding options or warrants as of the filing date, indicating limited equity-based compensation history but potential future issuance.

• · No stock-based compensation awards were granted to named executive officers for FY2024 or FY2025.
• · The Omnibus Plan has 6,300,000 shares available for future issuance with zero currently outstanding options or warrants.
• · The shareholder loyalty program would require further Board action, stockholder approval of a dedicated share reserve, an effective registration statement, and Nasdaq compliance.
• · Major shareholders include BCM Europe AG (24.3%), Bellevue Capital Management LLC (8.9%), and Joint Protein Central (7.4%).
• · The authorized share increase is not in response to any known takeover effort but could have anti-takeover effects.

16-07-2026

Plum Acquisition Corp. III filed a definitive proxy statement (DEF 14A) to hold an extraordinary general meeting on July 29, 2026, seeking shareholder approval to extend the deadline to complete its previously announced business combination with Tactical Resources Corp. from July 30, 2026 to December 31, 2026. The trust account holds approximately $501,297 as of July 15, 2026, with a redemption price of ~$11.80 per share, while the last quoted market price was $10.40 on May 1, 2026, creating a potential arbitrage for redeeming shareholders. However, the company faces the risk of liquidation if the extension is not approved and the business combination fails to close by the original deadline.

• · The meeting will be held at the offices of Hogan Lovells Cadwalader US LLP, 390 Madison Ave, New York, NY 10017.
• · The record date for shareholders entitled to vote is July 9, 2026.
• · Shareholders who previously submitted Class A shares for redemption in connection with the December 2025 extraordinary general meeting must re-instruct the transfer agent to redeem those shares in connection with the Articles Extension.
• · The Extension Amendment Proposal requires a two-thirds majority of votes cast; the Adjournment Proposal requires a simple majority.
• · If the extension is not approved, Plum may be forced to liquidate even if shareholders favor the business combination.

16-07-2026

Boot Barn Holdings, Inc. filed its definitive proxy statement (DEF 14A) on July 16, 2026, for the 2026 Annual Meeting of Stockholders to be held on August 26, 2026. The meeting will include the election of eight directors, a non-binding advisory vote on executive compensation (say-on-pay), approval of the 2026 Equity Incentive Plan, and ratification of Deloitte & Touche LLP as independent auditor for fiscal 2027. The proxy statement provides detailed compensation information for named executive officers, including CEO John Hazen, and discloses corporate governance practices.

• · The proxy statement and form of proxy were first distributed and made available on or about July 16, 2026.
• · The record date for stockholders entitled to vote is July 1, 2026.
• · The meeting will be an in-person only meeting at the company's headquarters in Irvine, California.
• · Stockholders will vote on a non-binding advisory proposal to approve fiscal 2026 executive compensation (say-on-pay).
• · The company is seeking approval of the Boot Barn Holdings, Inc. 2026 Equity Incentive Plan.
• · The ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending March 27, 2027 is proposed.

16-07-2026

Quoin Pharmaceuticals Ltd. filed a DEF 14A proxy statement on July 16, 2026, for its 2026 Annual General Meeting of Shareholders to be held on August 20, 2026. The meeting will include votes on the election of seven directors, an advisory vote on executive compensation, changes to non-employee director compensation, changes to 401(k) matching contributions, and the appointment of CBIZ CPAs P.C. as independent auditor. The record date is July 15, 2026, with 70,294,615 ordinary shares issued and outstanding (represented by 2,008,418 ADSs, each ADS representing 35 ordinary shares). No financial results or period-over-period comparisons are included in this filing.

• · The quorum requirement is 33 1/3% of voting power; if not met within half an hour, the meeting is adjourned for one day, after which any number of shareholders present constitutes a lawful quorum.
• · Proxies must be received by Quoin at least 24 hours prior to the scheduled meeting time for ordinary shareholders; ADS holders follow instructions on their proxy cards.
• · The Board recommends a vote 'FOR' all five proposals.
• · If a proxy card is returned without specifying a vote on a particular proposal, the shares will be deemed to have abstained on that proposal.

16-07-2026

Data Storage Corp filed a definitive proxy statement (DEF 14A) for its 2026 Annual Meeting to be held on September 2, 2026. The company completed the sale of its CloudFirst business in September 2025 for gross proceeds of $40 million, driving net income of $19.2 million for fiscal 2025, and subsequently repurchased approximately 72% of its outstanding common stock via a tender offer in January 2026. However, the company's continuing operations are now limited to its Nexxis Inc. subsidiary, and the Board is actively evaluating strategic alternatives including potential acquisitions and new organic initiatives, with no definitive transactions yet agreed upon.

• · The company maintains a Nasdaq listing and a debt-free balance sheet.
• · The Board has formed a Mergers & Acquisitions Committee to evaluate strategic alternatives.
• · The record date for the annual meeting is July 6, 2026.
• · Shareholders will vote on three proposals: election of ten directors, ratification of auditor, and advisory approval of executive compensation.
• · The company's continuing operating business is Nexxis Inc., which provides voice, data and SD-WAN solutions.

16-07-2026

CSW Industrials, Inc. filed its definitive proxy statement (DEF 14A) for the 2026 Annual Meeting of Shareholders, to be held on August 27, 2026. The filing highlights record fiscal 2026 results with revenue of $1.1B (+23.2% YoY), adjusted EBITDA of $270M (+18.3% YoY), and adjusted EPS of $10.38 (+6.9% YoY), driven by over $1.0B in acquisition capital deployed across five deals. However, operating cash flow declined 11.1% YoY to $150M, and the company notes challenged end markets due to tariffs and macroeconomic volatility. Shareholders will vote on the election of seven director nominees, an advisory 'Say on Pay' vote, and ratification of Grant Thornton LLP as auditor.

• · The proxy statement was first mailed on or about July 16, 2026 to shareholders of record as of July 8, 2026.
• · The annual meeting will be held virtually at www.virtualshareholdermeeting.com/CSW2026.
• · The Board has a Lead Independent Director who chairs executive sessions of independent directors.
• · Six of seven director nominees are independent; the CEO is the only management director.
• · 43% of director nominees are female and/or diverse.
• · Directors and executive officers are subject to robust stock ownership requirements.
• · The Board maintains an age-based retirement limit for directors at age 73.
• · All Board members are elected annually.
• · The company returned almost $150 million of capital to shareholders in fiscal 2026 through share repurchases and dividends.
• · The company has $420M available on its $700M revolving credit facility and $34M cash on hand.

16-07-2026

GSI Technology, Inc. filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders to be held virtually on August 20, 2026. Stockholders will vote on three proposals: electing five directors, ratifying BDO USA, P.C. as independent auditor for fiscal 2027, and an advisory vote on fiscal 2026 executive compensation. The Board recommends a vote FOR all proposals.

• · The annual meeting will be a completely virtual meeting via audio webcast at https://meetnow.global/MSH2UA9.
• · Stockholders of record as of July 1, 2026 are entitled to vote.
• · Proxies must be received by 5:00 p.m. EDT on August 10, 2026 for beneficial owners to register.
• · Directors are elected by plurality vote; Proposals 2 and 3 require majority of votes cast.
• · Broker non-votes and abstentions will have no effect on any of the three proposals.

16-07-2026

Actelis Networks Inc. filed a definitive proxy statement (DEF 14A) for its 2026 Annual Meeting of Stockholders to be held on August 25, 2026. Key proposals include electing Class I directors (Julie Kunstler and Gideon Marks), ratifying PwC as independent auditor, and increasing authorized common stock from 30 million to 80 million shares. The company had 25,837,246 shares outstanding as of the record date, and a quorum requires one-third of outstanding shares (8,612,416).

• · Meeting location: 25 Bazel Street, Petach Tikva, Israel 4951038
• · Record date for voting: June 29, 2026
• · Proxy materials mailed on or about July 16, 2026
• · Proposal No. 4: Adjournment if insufficient votes for Proposals 1, 2, or 3
• · Board recommends FOR all proposals (1, 2, 3)
• · No fee required for filing

16-07-2026

Agilysys, Inc. filed its definitive proxy statement (DEF 14A) for the 2026 Annual Meeting of Stockholders to be held virtually on September 2, 2026. The meeting will include the election of eight director nominees, a non-binding advisory vote on executive compensation, and ratification of Grant Thornton LLP as the independent auditor for fiscal year 2027. The filing details executive compensation for fiscal year 2026, including pay versus performance disclosures, and outlines corporate governance practices.

• · Annual Meeting will be held virtually on September 2, 2026 at 5:00 PM ET.
• · Record date for voting is July 6, 2026.
• · Proxy materials first made available on or about July 16, 2026.
• · Stockholders can access the meeting at https://meetnow.global/AGYS2026.
• · Proposals include election of directors, advisory vote on executive compensation, and ratification of auditor.
• · The filing includes a Compensation Discussion and Analysis section for fiscal year 2026.

16-07-2026

Indaptus Therapeutics, Inc. filed a definitive proxy statement (DEF 14A) for its 2026 Annual Meeting of Stockholders to be held virtually on August 10, 2026. The Board recommends voting FOR the election of Class II directors David Natan, Tim Ruan, and Johnny Fox Arrowsmith (Yi Zhang); ratification of Haskell & White LLP as independent auditor; and approval of the 2026 Equity Incentive Plan. As of the record date June 12, 2026, there were 113,242,324 shares of common stock outstanding and entitled to vote. The filing contains no financial results or period-over-period comparisons.

• · Annual Meeting will be held virtually via live webcast at https://meeting.vstocktransfer.com/INDAPTUSAUG26 on August 10, 2026 at 10:00 AM Eastern Time.
• · Record date for voting is June 12, 2026.
• · Quorum requirement is at least 33.3% of voting power outstanding.
• · Proxy materials will be mailed on or about July 29, 2026.
• · Stockholders holding shares in 'street name' must obtain a legal proxy from their bank or broker to vote virtually.
• · A Zoom account is required to register for the virtual meeting.

16-07-2026

AuguStar Variable Insurance Products Fund Inc. filed a definitive proxy statement (DEF 14A) for a special shareholder meeting on August 26, 2026. Shareholders will vote on three proposals: electing Julia W. Poston as an independent director (Proposal 1), reauthorizing a 'manager of managers' structure for 19 portfolios (Proposal 2), and changing two portfolios from diversified to non-diversified classification (Proposal 3). The Board unanimously recommends a vote FOR all proposals.

• · The special meeting will be held on August 26, 2026 at 9:00 am ET at One Financial Way, Montgomery, Ohio 45242.
• · Proposal 2 applies to 19 MoM Portfolios; the manager of managers order was previously obtained from the SEC but the MoM Portfolios agreed not to rely on it until shareholder approval is obtained.
• · Proposal 3 applies only to BlackRock Advantage Large Cap Growth Portfolio and AVIP Fidelity Institutional AM® Equity Growth Portfolio.
• · The Substitution Order and Correspondence Substitutions (2022, 2023, 2025) are separate from the Fund's operations and relate only to the Insurers' separate accounts.
• · Shareholders can vote by returning the voting instruction card, by telephone, or over the internet.